IBRX Donald Trump's approach to using import restrictions to lower drug prices highlights the ongoing tension between the US and global pharmaceutical companies. With the US being the largest market for big pharma, this move could significantly impact the sector, particularly in countries like Ireland, where a substantial portion of exports is tied to the pharmaceutical industry. So US Medicines factories flourish and their profits rises